Transforming Clinical Trials with AI: AlphaLife Sciences at B Capital’s 2024 Annual Event
Oct 04, 2024
Excited to be part of B Capital's 2024 Annual Asia Event in Singapore, where we explored strategies for global healthcare expansion.
Key insights from Alice Hsu, SVP of Clinical Technology Services:
Digital Transformation in Clinical Trials
At AlphaLife Sciences, we’re driving innovation in clinical trials with AuroraPrime, our GenAI-powered solutions. From medical writing to data management, our scalable, regionally adaptable solutions are trusted by industry leaders like Johnson & Johnson Innovation JLABS, Microsoft Pegasus Program, Google for Startups, and NVIDIA Inception Program.
Global Reach, Local Impact
With the rise of multi-regional clinical trials (MRCT), our GenAI solutions—like MedDRA-compliant translations and streamlined clinical documents such as Clinical Study Reports (CSRs)—are enhancing data quality for top pharma clients worldwide.
Partnerships Powering Innovation
Our collaborations with CROs and global pharma companies have demonstrated the real-world benefits of GenAI through pilot programs. Our strategic alliance with Microsoft Marketplace further accelerates global growth and efficiency.
It was an honor to share the panel with Insilico Medicine, Meditrust Group, and Spectrumedics! Special thanks to ProfoundBio and Cooley LLP for their valuable insights.
